Derek Lee
Direktor/Vorstandsmitglied bei Coagulo Medical Technologies, Inc.
Profil
Derek Lee is currently a Director at Coagulo Medical Technologies, Inc. He is also a Senior Advisor at Athyrium Capital Management (Private Equity) and Athyrium Capital Management LP.
Previously, he worked as a Principal at SV Health Investors LLC and as a Senior Analyst at Burrage Capital Management LLC.
Mr. Lee completed his undergraduate degree at Bentley University.
Aktive Positionen von Derek Lee
| Unternehmen | Position | Beginn |
|---|---|---|
Coagulo Medical Technologies, Inc.
 Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | Direktor/Vorstandsmitglied | - |
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Berater | - |
Ehemalige bekannte Positionen von Derek Lee
| Unternehmen | Position | Ende |
|---|---|---|
Burrage Capital Management LLC
 Burrage Capital Management LLC Financial ConglomeratesFinance Burrage Capital Management LLC (BCM) is a registered independent investment adviser and hedge fund manager founded in 2011. Headquartered in Boston, Massachusetts, BCM provides investment advice to high-net worth individuals. They have a focus on biotechnology and medical technology. | Analyst-Equity | - |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Corporate Officer/Principal | - |
Ausbildung von Derek Lee
| Bentley University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Finance |
Burrage Capital Management LLC
Burrage Capital Management LLC Financial ConglomeratesFinance Burrage Capital Management LLC (BCM) is a registered independent investment adviser and hedge fund manager founded in 2011. Headquartered in Boston, Massachusetts, BCM provides investment advice to high-net worth individuals. They have a focus on biotechnology and medical technology. | Finance |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | Technology Services |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Finance |
